The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Level Of Market Value Growth Is Predicted For The Open-Angle Glaucoma (OAG) Market From 2026 To 2030?
The open-angle glaucoma (oag) market size has demonstrated robust expansion recently. It is forecast to rise from $6.53 billion in 2025 to $6.96 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.5%. Historically, this growth can be attributed to several factors, including limited access to in-person mental health services, the increasing prevalence of anxiety and depression, heightened awareness of mental health importance, the expanding use of early telemedicine platforms, and the initial adoption of online counseling programs.
The market for open-angle glaucoma (oag) is anticipated to experience substantial growth over the coming years. Projections indicate it will reach $8.86 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.2%. This expansion during the forecast period is fueled by several factors, including an escalating demand for easily accessible online therapy, a rise in the uptake of mobile and web-based counseling tools, the increasing integration of AI-powered mental wellness solutions, a growing preference for hybrid therapy models that combine individual and group sessions, and the broader availability of online therapy services across both commercial and residential sectors. Key trends anticipated during this period encompass the growing acceptance of prostaglandin analog drugs, a greater reliance on minimally invasive glaucoma surgeries, enhanced awareness leading to earlier diagnosis and screening, an uptick in teleophthalmology consultations for managing OAG, and continued advancements in combination drug therapies.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20911&type=smp
What Factors Are Contributing To The Growth Of The Open-Angle Glaucoma (OAG) Market?
Increased understanding of eye diseases is projected to drive the expansion of the open-angle glaucoma (OAG) market in the future. Eye diseases encompass various medical conditions affecting the structure, function, or sight of the eyes, ranging from minor issues like dry eye to severe conditions such as glaucoma and macular degeneration. Their occurrence is rising due to an aging global population, extended periods of screen usage, an increase in diabetes cases, environmental pollutants, and lifestyle choices that negatively impact eye health. Open-angle glaucoma (OAG), a primary cause of blindness, particularly in older individuals, highlights the vital necessity for regular eye check-ups, prompt diagnosis, and active treatment to prevent permanent vision impairment. For instance, in October 2023, according to the Royal National Institute of Blind People (RNIB), a UK-based sight loss charity, eye care outpatient appointments in the UK surpassed eight million in 2021/22, making it the most sought-after medical specialty. Additionally, the population with sight loss, which currently exceeds two million, is expected to double to more than four million by 2050. Consequently, heightened awareness of eye illnesses is fueling growth in the open-angle glaucoma (OAG) market.
Which Segment Classifications Are Used In The Open-Angle Glaucoma (OAG) Market Segment Analysis?
The open-angle glaucoma (oag) market covered in this report is segmented –
1) By Disease Type: Open Angle Glaucoma, Angle Closure Glaucoma, Other Disease Types
2) By Drug Class: Prostaglandin Analog, Beta Blockers, Adrenergic Agonist, Carbonic Anhydrase Inhibitors, Other Drug Classes
3) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users
4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
Subsegments:
1) By Open Angle Glaucoma (OAG): Primary Open-Angle Glaucoma (POAG), Secondary Open-Angle Glaucoma
2) By Angle Closure Glaucoma: Acute Angle-Closure Glaucoma, Chronic Angle-Closure Glaucoma
3) By Other Disease Types: Normal-Tension Glaucoma, Congenital Glaucoma, Secondary Glaucoma
What Trends Are Shaping The Future Of The Open-Angle Glaucoma (OAG) Market?
Major companies within the open-angle glaucoma (OAG) market are prioritizing the development of innovative solutions, such as minimally invasive glaucoma devices (MIGDs), to provide advanced and less intrusive alternatives for managing primary open-angle glaucoma, thereby reducing reliance on traditional treatments. A minimally invasive glaucoma device (MIGD) refers to a variety of surgical implants and techniques designed to lower intraocular pressure in glaucoma patients through small incisions and minimal disruption of ocular tissues. For instance, in December 2023, iSTAR Medical, a Belgium-based medtech company, launched MINIject in the Netherlands. This bio-integrating treatment for primary open-angle glaucoma utilizes a unique porous STAR material to enhance fluid outflow and reduce IOP. By decreasing dependency on conventional therapies, MINIject represents a significant breakthrough in glaucoma care, offering a safer and more effective management option for this leading cause of permanent blindness.
Which Firms Are Contributing To The Open-Angle Glaucoma (OAG) Market Ecosystem?
Major companies operating in the open-angle glaucoma (oag) market are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Novartis AG, Teva Pharmaceutical Industries Ltd., Alcon Inc., Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Santen Pharmaceuticals, Théa Pharma, Glaukos Corporation, Quantel Medical, EyePoint Pharmaceuticals Inc., iSTAR Medical, Nicox Ophthalmics, Visus Therapeutics, Inotek Pharmaceuticals, Hoya Corporation, Boston Scientific, Ocular Therapeutix Inc., Carl Zeiss Meditec AG, Topcon Corporation, Nidek Co. Ltd., Heidelberg Engineering GmbH, New World Medical Inc.
Get The Full Open-Angle Glaucoma (OAG) Market Report:
https://www.thebusinessresearchcompany.com/report/open-angle-glaucoma-oag-global-market-report
Which Region Leads The Open-Angle Glaucoma (OAG) Market In Overall Market Size?
North America was the largest region in the open-angle glaucoma (OAG) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the open-angle glaucoma (oag) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Open-Angle Glaucoma (OAG) Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/report/open-angle-glaucoma-oag-global-market-report
Browse Through More Reports Similar to the Global Open-Angle Glaucoma (OAG) Market 2026, By The Business Research Company
Onychomycosis Market Report 2026
https://www.thebusinessresearchcompany.com/report/onychomycosis-global-market-report
Yeast Infection Treatment Market Report
https://www.thebusinessresearchcompany.com/report/yeast-infection-treatment-global-market-report
Aspergillosis Treatment Market Report
https://www.thebusinessresearchcompany.com/report/aspergillosis-treatment-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model